Well-water Consumption and Parkinson's Disease in Rural California
Overview
Affiliations
Introduction: Investigators have hypothesized that consuming pesticide-contaminated well water plays a role in Parkinson's disease (PD), and several previous epidemiologic studies support this hypothesis.
Objectives: We investigated whether consuming water from private wells located in areas with documented historical pesticide use was associated with an increased risk of PD.
Methods: We employed a geographic information system (GIS)-based model to estimate potential well-water contamination from agricultural pesticides among 368 cases and 341 population controls enrolled in the Parkinson's Environment and Genes Study (PEG). We separately examined 6 pesticides (diazinon, chlorpyrifos, propargite, paraquat, dimethoate, and methomyl) from among 26 chemicals selected for their potential to pollute groundwater or for their interest in PD, and because at least 10% of our population was exposed to them.
Results: Cases were more likely to have consumed private well water and to have consumed it on average 4.3 years longer than controls (p = 0.02). High levels of possible well-water contamination with methomyl [odds ratio (OR) = 1.67; 95% confidence interval (CI), 1.00-2.78]), chlorpyrifos (OR = 1.87; 95% CI, 1.05-3.31), and propargite (OR = 1.92; 95% CI, 1.15-3.20) resulted in approximately 70-90% increases in relative risk of PD. Adjusting for ambient pesticide exposures only slightly attenuated these increases. Exposure to a higher number of water-soluble pesticides and organophosphate pesticides also increased the relative risk of PD.
Conclusion: Our study, the first to use agricultural pesticide application records, adds evidence that consuming well water presumably contaminated with pesticides may play a role in the etiology of PD.
Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications.
Atterling Brolin K, Schaeffer E, Kuri A, Rumrich I, Schumacher Schuh A, Darweesh S Mov Disord. 2024; 40(2):204-221.
PMID: 39601461 PMC: 11832802. DOI: 10.1002/mds.30067.
Chen Y, Yang Z, Nian B, Yu C, Maimaiti D, Chai M Neuropsychiatr Dis Treat. 2024; 20:2237-2254.
PMID: 39588175 PMC: 11587806. DOI: 10.2147/NDT.S479757.
A study on possible risk factors for progressive supranuclear palsy in southern part of India.
Thomas A, Mohan M, Thomas R Curr J Neurol. 2024; 23(1):66-73.
PMID: 39431234 PMC: 11489628. DOI: 10.18502/cjn.v23i1.16434.
The Body, the Brain, the Environment, and Parkinson's Disease.
Ray Dorsey E, De Miranda B, Horsager J, Borghammer P J Parkinsons Dis. 2024; 14(3):363-381.
PMID: 38607765 PMC: 11091648. DOI: 10.3233/JPD-240019.
Towards improved screening of toxins for Parkinson's risk.
Shan L, Heusinkveld H, Paul K, Hughes S, Darweesh S, Bloem B NPJ Parkinsons Dis. 2023; 9(1):169.
PMID: 38114496 PMC: 10730534. DOI: 10.1038/s41531-023-00615-9.